These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8233614)

  • 21. Curcumin for malaria therapy.
    Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin derivatives inhibit the growth of malarial parasites in mice.
    Ohnishi ST; Ohnishi N; Oda Y; Katsuoka M
    Cell Biochem Funct; 1989 Apr; 7(2):105-9. PubMed ID: 2766469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria. Signs of drug resistance rattle experts, trigger bold plan.
    Enserink M
    Science; 2008 Dec; 322(5909):1776. PubMed ID: 19095911
    [No Abstract]   [Full Text] [Related]  

  • 24. Parasitic pattern of rodent Plasmodium in blood from mouse tail and from Anopheles blood meal.
    Landau I; Chabaud A
    Parassitologia; 2002 Jun; 44(1-2):111-5. PubMed ID: 12404818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of events preceding the release of malaria parasite from the host red blood cell.
    Soni S; Dhawan S; Rosen KM; Chafel M; Chishti AH; Hanspal M
    Blood Cells Mol Dis; 2005; 35(2):201-11. PubMed ID: 16087367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium vinckei vinckei, P. v. lentum and P. yoelii yoelii: chronobiology of the asexual cycle in the blood.
    Gautret P; Deharo E; Chabaud AG; Ginsburg H; Landau I
    Parasite; 1994 Sep; 1(3):235-9. PubMed ID: 9140490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
    Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
    Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the antimalarial toolkit: Targeting host-parasite interactions.
    Langhorne J; Duffy PE
    J Exp Med; 2016 Feb; 213(2):143-53. PubMed ID: 26834158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biology of malaria parasites. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1987; 743():1-229. PubMed ID: 3109131
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of daphnetin on the exo-erythrocytic stage of rodent malaria].
    Liu YG; Wang QM; Xu YQ; Ni QZ; Ni YC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(1):30-2. PubMed ID: 12572020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New malaria drugs: screening against the entire parasite or target-based - which is the right path?].
    Schlitzer M
    Pharm Unserer Zeit; 2011 May; 40(3):190-1. PubMed ID: 21698606
    [No Abstract]   [Full Text] [Related]  

  • 34. Latency of Plasmodium merozoites and drug-resistance. A review.
    Landau I; Chabaud AG
    Parasite; 1994 Jun; 1(2):105-14. PubMed ID: 9140478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
    Becker K; Tilley L; Vennerstrom JL; Roberts D; Rogerson S; Ginsburg H
    Int J Parasitol; 2004 Feb; 34(2):163-89. PubMed ID: 15037104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status and evolution of antimalarial drug resistance (with special reference to chloroquine and related blood schizontocides).
    Warhurst DC
    J Chemother; 1989 Jul; 1(4 Suppl):407-10. PubMed ID: 16312461
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi Malaria to various drugs and their combinations.
    Rahman NN
    Med J Malaysia; 1997 Dec; 52(4):390-8. PubMed ID: 10968116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis.
    Buckling A; Crooks L; Read A
    Exp Parasitol; 1999 Sep; 93(1):45-54. PubMed ID: 10464038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.